Component
Mouse p27 / Cdkn1b
Context-specific entity; species, compartment and exposure are stated on each claim.
3 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What it acts on
Cdkn1b interference reduced fisetin protection against high-glucose injury in mouse podocytes.
Experimental context and source evidence
- availability_state
- machinery_impairment Imported condition classification; unverified.
- evidence_access
- Primary full text
- experimental_model
- Mouse podocyte gene-interference experiment.
- limitations
- A pathway dependency, not evidence of a nutritional deficiency.
- nutrient_topic
- Fisetin collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Fisetin
- plain_language
- Disrupting the regulator weakened protection.
- primary_references
- Fisetin Attenuates Diabetic Nephropathy-Induced Podocyte Injury by Inhibiting NLRP3 Inflammasome. · 2022 · https://pubmed.ncbi.nlm.nih.gov/35126159/ · DOI 10.3389/fphar.2022.783706
- trigger_kind
- machinery_impairment Imported condition classification; unverified.
Fisetin: metabolism, cell-state responses and cross-nutrient mechanisms (2026-09-19) · lines 408–414
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Mouse podocyte gene-interference experiment. · source_derived_draft · unverified_draft
## fisetin-podocyte-p27-loss Disrupting the regulator weakened protection. Cdkn1b interference reduced fisetin protection against high-glucose injury in mouse podocytes. Model: Mouse podocyte gene-interference experiment. Limitations: A pathway dependency, not evidence of a nutritional deficiency. Evidence access: Primary full text Fisetin Attenuates Diabetic Nephropathy-Induced Podocyte Injury by Inhibiting NLRP3 Inflammasome. · 2022 · https://pubmed.ncbi.nlm.nih.gov/35126159/ · DOI 10.3389/fphar.2022.783706
Complete structured claim and evidence
What acts on it
Fisetin restored Cdkn1b expression in high-glucose-exposed mouse podocytes and diabetic mouse kidney.
Experimental context and source evidence
- evidence_access
- Primary full text
- experimental_model
- Immortalized mouse podocytes and streptozotocin diabetic mice.
- limitations
- Docking suggests a possible interaction but does not demonstrate direct binding.
- nutrient_topic
- Fisetin collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Fisetin
- plain_language
- A cell-cycle regulator was linked to protection.
- primary_references
- Fisetin Attenuates Diabetic Nephropathy-Induced Podocyte Injury by Inhibiting NLRP3 Inflammasome. · 2022 · https://pubmed.ncbi.nlm.nih.gov/35126159/ · DOI 10.3389/fphar.2022.783706
Fisetin: metabolism, cell-state responses and cross-nutrient mechanisms (2026-09-19) · lines 392–398
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Immortalized mouse podocytes and streptozotocin diabetic mice. · source_derived_draft · unverified_draft
## fisetin-podocyte-p27 A cell-cycle regulator was linked to protection. Fisetin restored Cdkn1b expression in high-glucose-exposed mouse podocytes and diabetic mouse kidney. Model: Immortalized mouse podocytes and streptozotocin diabetic mice. Limitations: Docking suggests a possible interaction but does not demonstrate direct binding. Evidence access: Primary full text Fisetin Attenuates Diabetic Nephropathy-Induced Podocyte Injury by Inhibiting NLRP3 Inflammasome. · 2022 · https://pubmed.ncbi.nlm.nih.gov/35126159/ · DOI 10.3389/fphar.2022.783706
Complete structured claim and evidence
Where it participates (unsigned role)
Fisetin reduced p70S6K phosphorylation, increased autophagosome formation and suppressed inflammasome readouts in mouse podocyte models.
Experimental context and source evidence
- evidence_access
- Primary abstract
- experimental_model
- Mouse podocytes and diabetic kidney study.
- limitations
- Autophagosome number alone does not establish complete autophagic flux.
- nutrient_topic
- Fisetin collection; molecular form, preparation, species, exposure and manipulation remain explicit. · Fisetin
- plain_language
- Protein recycling and inflammatory signaling changed together.
- primary_references
- Fisetin Attenuates Diabetic Nephropathy-Induced Podocyte Injury by Inhibiting NLRP3 Inflammasome. · 2022 · https://pubmed.ncbi.nlm.nih.gov/35126159/ · DOI 10.3389/fphar.2022.783706
Fisetin: metabolism, cell-state responses and cross-nutrient mechanisms (2026-09-19) · lines 400–406
AI-assisted research curation; primary references, access levels and experimental limitations individually identified. Not publisher full text. · supports · Mouse podocytes and diabetic kidney study. · source_derived_draft · unverified_draft
## fisetin-podocyte-autophagy Protein recycling and inflammatory signaling changed together. Fisetin reduced p70S6K phosphorylation, increased autophagosome formation and suppressed inflammasome readouts in mouse podocyte models. Model: Mouse podocytes and diabetic kidney study. Limitations: Autophagosome number alone does not establish complete autophagic flux. Evidence access: Primary abstract Fisetin Attenuates Diabetic Nephropathy-Induced Podocyte Injury by Inhibiting NLRP3 Inflammasome. · 2022 · https://pubmed.ncbi.nlm.nih.gov/35126159/ · DOI 10.3389/fphar.2022.783706
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.